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Imaging plays many essential roles in nearly all aspects of high-quality cancer care. However, challenges to
the delivery of optimal cancer imaging in both developing and advanced countries are manifold. Developing
countries typically facedramatic shortagesof both imagingequipment andgeneral radiologists, andefforts
to improve cancer imaging in these countries are often complicated by poor infrastructure, cultural
barriers, and other obstacles. In advanced countries, on the other hand, although imaging equipment and
general radiologists are typically accessible, the complexity of oncologic imaging and the need for
subspecialists in the field are largely unrecognized; as a result, training opportunities are lacking, and
there is a shortage of radiologistswith the necessary subspecialty expertise to provide optimal cancer care
and participate in advanced clinical research. This article is intended to raise awareness of these
challenges and catalyze further efforts to address them. Some promising strategies and ongoing efforts are
reviewed, and some specific actions are proposed.
INTRODUCTION
Imaging plays many essential roles in nearly all as-
pects of high-quality cancer care, from diagnosis
through treatment and follow-up. Cross-sectional
imaging technologies now exist that can accurately
detect cancer, assess its spread, and, in some
cases, provide information about its biology. How-
ever, vast inequities in access to imaging equip-
ment and expertise exist between developing
and developed countries. Furthermore, even in
developed countries, the complexity of oncologic
imaging is underappreciated, and the supply of
imagerswith the specialized trainingnecessary to
provide optimal cancer care is far from adequate.
This article, which was inspired by discussions
held at and after the 2014 meeting of the In-
ternational Cancer Imaging Society, is intended
to increase awareness of these challenges and
catalyze further efforts to overcome them. Some
promising strategies and ongoing efforts to ad-
vance cancer imaging are reviewed, and some
specific actions are proposed.
INEQUITIES IN PATIENT OUTCOMES FOR PATIENTS
WITH CANCER, HEALTH CARE SPENDING, AND
IMAGING AVAILABILITY
Cancer is the world’s leading cause of death, and
it is expected that by 2030, the number of new
cancer cases per year, which was estimated at 14
million in 2012, will have increased by more than
50%, to 22 million.1 Both the majority of cancer
cases and themajority of cancer deathsnowoccur
in developing nations, where resources for coping
with cancer are least available.2
Although the direct effects of imaging on long-
term patient outcomes have not been studied
extensively and are difficult to isolate and quantify,
in regions with better cancer outcomes, imaging is
considered a cornerstone of cancer care. A study
conducted in Europe showed not only that all-
cancer relative survival wasbetter in countrieswith
higher overall health care expenditures and greater
numbers of computed tomography (CT) andmag-
netic resonance imaging (MRI) units per capita
but also that it correlated directly with the num-
ber of MRI units per capita—a finding the au-
thors described as “consistent with the known
importance of early and accurate diagnosis in
cancer survival.”3(p85) Imaging allows cancers to
be detected when they are smaller and more
likely to be curable. For example, growing use of
mammography has lowered the stage of breast
cancersatdiagnosisand, togetherwithadvances in
treatment, has contributed to increases in breast
cancer survival observed in Europe, the United
States, Australia, South Korea, Japan, and Sin-
gapore.4-7 The use of imaging for staging can
often replace more invasive staging procedures
and is critical for determining the most appro-
priate treatment approach and enabling mini-
mally invasive treatments. Furthermore, imaging is
usedroutinely forassessing responses tonumerous
cancer therapiesanddetermining theeffectiveness
and duration of treatment.
Defining the optimal numbers of CT, MRI, or other
types of imagingunitspermillionpopulationwould
be a complex task andwould need to be done on a
country-by-country or evenmore localizedbasis. It
is clear that easy access to imagingequipment can
lead to its overuse—a problem that is exacerbated
when thephysicianswho refer patients for imaging
profit from its use.8 However, it is also clear that a
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lack of imaging equipment can lead to long wait
times for imaging examinations and create geo-
graphic barriers to access.9 Unfortunately, ineq-
uities in the distribution of imaging equipment
between economically advanced and developing
countries are pronounced. For example, the over-
all numbers of CT and MRI units per million in-
habitants are 24.1 and 18.5, respectively, in
Western Europe but just 13 and 6.5, respectively,
in Central and Eastern Europe.10 According to a
report published in 2015, the numbers of CT units
per million population among the 32 Organisation
for Economic Co-operation and Development coun-
tries ranged from 5.3 in Mexico to 101.3 in Japan at
last count.9
Within many developing countries—as well as
some economically advanced ones— inequities
in the availability, accessibility, and affordability of
imaging facilities among different geographic re-
gions and sectors of the population are also strik-
ing. In China in 2009, for example, Shanghai had
3.2MRI scanners permillion population, whereas
the rural province of Hunan had just 1.3.11 Al-
though China is estimated to have doubled its
high-end imaging technology resources from
2008 to 2012, at the end of that period, the
number of MRI scanners per unit population in
Shanghai remained twice that in Hunan.12
Highly uneven distribution of health care re-
sources between the public and private sectors
is also a common problem. For example, in Brazil,
public health care facilities tend to the needs of
approximately 75% of the population but possess
only approximately 16%ofCT scanners and6%of
MRI scanners.13 Similarly, in South Africa,. 90%
of the MRI scanners—as well as the majority
of radiologists—are located in the private sector,
which cares for only approximately 16% of
the population.14
GAPS IN IMAGING EXPERTISE IN HIGHER-INCOME
COUNTRIES
With the increasing demand for cancer imaging
worldwide, there is a growing need for expertise in
the performance and reporting of oncology exam-
inations. It is not surprising that in low-income
countries, where general radiologists are in short
supply, cancer imaging expertise is scarce. How-
ever, there is little awareness that even in econom-
ically advanced countries such as the United
States, where imaging services are widely avail-
able and a large share of the examinations
performed by radiology practices are oncologic
imaging studies, the shortage of trained oncologic
imagers is anobstacle to thedelivery, aswell as the
advancement, of high-quality cancer care. This
section discusses the need to foster specialized
cancer imaging expertise to optimize cancer care
in higher-incomecountrieswith soundhealth care
infrastructures.
High-quality imaging requires multifaceted,
disease-specific knowledge and sophisticated
communication skills. It entails effective planning
and performance of the examination itself, image
postprocessing, image interpretation, and clini-
cally relevant, standardized reporting. Not only
does the oncologic radiologist need to be familiar
with a variety of tumor entities, their patterns of
spread, and their appearances on various imaging
modalities, but he/she also needs to be able to
assess tumor response to15 and complications
from different therapies16 as well as the varying
patterns of tumor recurrence. In addition, he/she
must understand the practices and needs of the
various clinical partners (eg, from surgery, radia-
tion oncology, and medical oncology) involved in
cancer care.
Research has consistently shown that outcomes
are better for patients with cancer when they are
treated at dedicated tertiary care cancer centers
rather than in less-specialized settings. For exam-
ple, one recent analysis found that the risk-
adjusted probability of death at 1 year was 10
percentage points lower for patients treated at
freestanding specialty cancer hospitals than for
patients with cancer treated at community hospi-
tals in the United States.17 At many dedicated
tertiary care cancer centers and large hospitals
known for providing high-quality cancer care, the
optimal management of patients with cancer is
discussed at tumor conferences comprising spe-
cialized multidisciplinary teams, of which radiol-
ogists are integralmembers. Radiologistmembers
of these teams have subspecialized expertise and
are often asked to perform second-opinion report-
ing of oncologic imaging studies obtained at other
facilities. Second-opinion reporting by subspecial-
ized radiologists has been shown to improve di-
agnostic accuracy and affect patient care.18-20
In a study by Lakhman et al,21 for instance, two
gynecologic oncologic surgeons retrospectively
compared 469 consecutive second-opinion MRI
interpretations rendered by gynecologic-oncologic
radiologists to the initial outside reports; for each
surgeon, it was found that second-opinion review of
gynecologicMRIs would have affected themanage-
ment of at least 20% of patients and would have
changed patient management from a surgical to a
nonsurgical approach for approximately 7% of pa-
tients. Comparison with histopathology or minimum
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6-month imaging follow-up showed that second-
opinion interpretations were correct in 103 (83%)
of 124 cases with clinically relevant discrepancies
between initial and second-opinion reports.21
Table 1 summarizes the results of this and other
recent studies comparing initial oncologic imaging
readings with second-opinion readings performed
at comprehensive cancer centers; as shown, the
reported levels of disagreement between initial and
second-opinion readings range from 13% to 56%,
whereas the reported percentages of cases for
which second-opinion readings indicated the need
for a change in management range from 13% to
53.5%.19,21-29Requests forsecond-opinionreport-
ing are continually increasing and constitute a con-
siderable part of the subspecialized radiologist’s
workload in larger centers. However, although it
is essential to the overall quality of oncologic imag-
ing services, second-opinion reporting is currently
not widely reimbursed outside of the United States.
In economically advanced countries, the need for
specialization in (and within) oncologic imaging is
being exacerbated by the increasing use of mo-
lecularly targeted treatments and immunother-
apy, for which response assessment on imaging
is often complex. Because the mechanisms of
action of most targeted treatments differ from
those of traditional cytotoxic chemotherapies, a
variety of new imaging-based response assess-
ment criteria have been developed, and more
are needed.15 Examples of response assessment
criteria developed as a result of newly available
therapies in recent years include the Choi crite-
ria for gastrointestinal stromal tumors and the
Immune-Related Response Criteria, as well as
the recently published modified Response Evalu-
ation Criteria in Solid Tumors 1.1 for immune-
based therapeutics.30-32 Disease-specific criteria
include the Lugano classification for lymphomas,
recently published provisional recommendations
as a refinement of the latter for patients receiving
immunomodulatory therapies,33,34 and the just-
published proposed new response evaluation cri-
teria in lymphoma (RECIL 2017).35 Given that 10
new anticancer drugs received regulatory ap-
proval in the United States in 2014 alone, and
hundreds more are in development,36 it is easy to
appreciate why specialized knowledge of the var-
ious tumor response assessment criteria is impor-
tant for radiologists reporting in clinical trials.
Radiologists who have completed fellowships in
body imaging, chest imaging, or other areas can
acquire subspecialized expertise in imaging cer-
tain kinds of cancer by working in centers that
provide team-based, multidisciplinary cancer
care. In addition, some dedicated tertiary care
cancer centers offer fellowships specifically in
oncologic imaging subjects; these fellowships al-
low radiologists to develop subspecialty expertise
more rapidly and may also give them valuable
experience in cutting-edge research. Subspecial-
ization itself should furthermoreensure thatcutting-
edgeknowledge inoncologic imaging ismaintained
and advanced through ongoing training and close
and sustainable collaboration with a multidisciplin-
ary clinical oncology team.
Unfortunately, even in high-income countries
such as Japan, Korea, Hong Kong, and theUnited
States, oncologic imaging is still not a formally
recognized subspecialty for which certification is
available. In the United States, out of more than
200 imaging fellowships offered, only a handful
are formal oncologic imaging fellowships; further-
more, the supply of radiologists with any kind of
fellowship training is limited, and many imaging
facilities do not require it.
In the future, advanced computer tools for ana-
lyzing images (discussed more extensively in the
next section of this article) may help raise the
quality of oncologic imaging among general radi-
ologists as well as subspecialists. However, in
the nearer term, oneway to help optimize cancer
imaging in higher-income countries may be
through the development of second-opinion image
reporting services staffed and overseen by radiol-
ogists with subspecialty expertise in oncologic im-
aging. Some specialty cancer centers in theUnited
States are already successfully offering such
second-opinion services to patients being cared
for at other institutions. However, to help reach
all the patients who could potentially benefit from
second-opinion reporting, many more such ser-
vices would need to be established, and the supply
ofoncologic imagingsubspecialistsqualified tostaff
them would need to be expanded.
Professional societies must work together with
government policymakers to disseminate aware-
ness of the importance of specialized cancer
imaging expertise. In addition, professional soci-
eties should formally recognize oncologic imaging
as a subspecialty (or better yet, a set of subspe-
cialties), develop and promote practice standards
in oncologic imaging, develop training curricula
and fund fellowships and other training opportu-
nities in oncologic imaging, and encourage the
development of second-opinion reporting services
in oncologic imaging along with standards for
their accreditation.
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International efforts to advance some of these
goals have already begun. For example, to pro-
mote quality standards and the recognition of
oncologic imaging as a radiologic subspecialty,
the European Society of Radiology (ESR) has
included a chapter on oncologic imaging in both
the European Training Curriculum for Radiology
and the European Training Curriculum for Sub-
specialization in Radiology37,38; it is hoped that
this will encourage national societies to also in-
tegrate oncologic imaging in their radiology train-
ing curricula. In 2000, the International Cancer
Imaging Society was formed specifically to foster
education in oncologic imaging, stimulate re-
search, and bring together radiologists and cli-
nicians involved in cancer care. Subsequently,
the ESR founded the European Society of On-
cologic Imaging. Opportunities for education in
oncologic imaging—such as courses, workshops,
and onlinewebinars—are offeredby societies such
as the European Society of Oncologic Imaging,
the International Cancer Imaging Society, and
the Radiological Society of North America, to
name just a few.Opportunities formore intensive,
subspecialized training can also be accessed
through international societies. For example,
the European School of Radiology supplies ap-
plications to a number of short- and long-term
visiting scholarships and fellowships at centers of
excellence in Europe and the United States,
which are funded by the ESR, national societies,
the pharmaceutical industry, academic institu-
tions, and other sources.
Within the last 6 years, European initiatives have
also been launched to help standardize training
and practice in hybrid imaging (eg, positron
emission tomography–CT) and interventional
radiology—two areas of imaging that are becom-
ing increasingly important in cancer care.39,40,41
There is a need to increase collaborative efforts
with societies that are not focused on imaging,
such as the European Society for Medical Oncol-
ogy or the European Society for Radiotherapy and
Oncology, in the development of clinical practice
guidelines as well as educational and research
initiatives. Just as oncologic radiologists are key
members of disease management teams, they
need to be integrated into the leadership bodies
that design broad, cancer-related policies and
initiatives around the world.
EFFORTS AND STRATEGIES FOR IMPROVING THE
AVAILABILITY AND QUALITY OF ONCOLOGIC
IMAGING IN LOWER-INCOME REGIONS
In low-resource regions, a lack of imaging equip-
ment typically goes hand in hand with a paucity of
radiologists, and those radiologists who are pres-
ent are likely to face intense clinical workloads.
Although in the developed world, the existing
medical infrastructure enables medical subspeci-
alization and networking between different med-
ical facilities, the situation in the developing world
demands that radiologists, especially those work-
ing in smaller and geographically isolated com-
munity hospitals, have a great breadth of expertise.
Table 1. Summary of Results of Recent Studies Comparing Initial Oncologic Imaging Readings With Second-Opinion Readings Performed at
Comprehensive Cancer Centers
First Author Site Modalities No. Disagreement (%)
Change in
Management (%) Location of Institution
Coffey22 Breast MMG, US, MRI 200 28 13 United States
Ulaner23 Any PET/CT 240 13 — United States
Hansen24 Prostate MRI 158 54 — Germany/United
Kingdom
Woo25 Endometrium MRI 55 27.3 (DMI) — Korea
Hatzoglou26 Neurologic CT, MRI 283 19 15 United States
Lakhman21 Gynecologic MRI 469 — 20 (S1), 21.5 (S2) United States
Spivey27 Breast MMG, US 380 — 53.5 United States
Wibmer19 Prostate MRI 76 30 (ECE) — United States
Lysack28 Head and neck CT, MRI 94 56 38 Canada
Lorenzen29 Breast Real-time US, MMG 374 — 26 Germany
NOTE.Disagreement indicates thepercentageof cases inwhich initial and second-opinion readingsdisagreed.Change inmanagement indicates thepercentage of cases inwhich
second-opinion readings indicated the need for a change in management.
Abbreviations: DMI, deepmyometrial invasion; ECE, extracapsular extension;MMG,mammography;MRI, magnetic resonance imaging; PET/CT, positron emission tomography/
computed tomography; S1, surgeon 1; S2, surgeon 2; US, ultrasound.
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Not only do they need to be able to exploit all the
imaging methods available on site, they must also
be able to examine all body parts and meet the
requirements of the multidisciplinary therapy ap-
proaches available. Meeting these demands is, of
course, challenging, and a variety of obstaclesmay
complicate efforts to help.42 This section briefly
considers technological innovations that may help
to address the shortages of imaging equipment
and radiologists in low-resources areas; it then
reviews some promising efforts and strategies to
address these shortages that would benefit from
further engagement from the imaging and cancer
care communities.
HowCanCommunication Technology, Health Care
Informatics, and Artificial Intelligence Help?
The growth of the Internet has already made tele-
radiology part of the daily experience of many
radiologists. Oncologic radiologists are particularly
familiar with teleradiology, because imaging stud-
ies acquired at other institutions are transmitted to
their centers for second-opinion reporting and
follow-up assessment. More extensive radiology
consulting services can also be supplied remotely,
including recommendation and implementation
of state-of-the-art imaging protocols, quality con-
trol, image interpretation, and reporting of the
imaging studies according to the most recent
guidelines; in addition, clinical decision support
can be supplied via oncologic radiologists’ par-
ticipation in interdisciplinary tumor board ses-
sions (eg, through videoconferencing).43
Cross-border telemedicine has huge potential to
improve patient care in rural areas and developing
countries by providing access to specialist ser-
vices. By 2011, cross-border telemedicine pro-
grams had been attempted or were underway in at
least 76 countries, according to a systematic re-
view of the literature.44 Most of these were pilot
programs between high- and low- or middle-
income countries. The programs encountered a
variety of obstacles, particularly with regard to
funding, legal issues (eg, data security, liability),
cultural factors (eg, language, lack of mutual
trust), and contextual factors (eg, lack of reli-
able infrastructure for information exchange,
lack of resources to implement recommenda-
tions made by remote physicians). Although
many of the programs were found to be ineffec-
tive or unsustainable, those that fared best
tended to rely on low-cost technologies and in-
volve close twinning relationships with remote
academic centers that provided training and
mentorship of local personnel.44
The value of the global telemedicine market
reached approximately $17.879 million in 2015
and was expected to increase at a compound
annual growth rate of 18.7% from 2016 to
2022, according to one analysis.45 Technologies
for data transfer and storage are continuously
being developed, some of them specifically for
low-resource settings.46 Further advances in
health care informatics and the development
of supraregional networks will help to overcome
traditional barriers.44
Rapid developments in computerized clinical de-
cision support and artificial intelligence (AI) could
also be of particular value for advancing cancer
care in low-resource regions. Decision support
systems for selecting appropriate imagingmethods
and imaging protocols according to established
guidelines are increasingly being used in the de-
veloped world and could potentially be adapted for
manydifferent settings.Clinicaldecisionsupport for
radiologists has also been developed to promote
standardization of interpretation, terminology, and
follow-up recommendations during the generation
of imaging reports.47 Furthermore, various AI tech-
niques, such as neuronal networks, fuzzy logic,
evolutionary computation, deep learning, andcom-
puter vision are emerging, all of which are capable
of solving clinical problems. Computer-aided de-
tection and diagnosis (CAD) systems have evolved
to semiautomatically or even automatically detect
pulmonary nodules or breast lesions, among other
pathologies.48,49 CAD systems and other postpro-
cessing tools for image analysis hold great potential
to facilitate image interpretation in oncology by
aiding or automatically performing the detection,
segmentation, measurement, and even charac-
terization of suspicious lesions, as well as the
quantification of changes during treatment. As
suggested by Saurabh Jha and Eric Topol,50 the
use of computers to detect and characterize ab-
normalities could free up radiologists to act as in-
formation specialists, who would interpret the data
provided in its larger context, advise on the need for
any further diagnostic testing, and integrate find-
ings to guide treating physicians.50 If AI becomes
sufficiently accurate and reliable for lesion detec-
tionandcharacterization, it couldbeused to screen
populations faster than radiologists can and could
eventually lead to significant cost savings; in turn,
with the help of AI, a single information specialist
could then “manage screening for an entire town in
Africa,” Jha and Topol assert.50(p2354)
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Efforts and Strategies to Implement Change
As noted in “Public health oncology: a framework
for progress in low- and middle-income coun-
tries,” success in advancing cancer care in such
countries depends not just on the support of in-
ternational partners but, even more importantly,
on the engagement of local communities.42 It is
essential that local stakeholders take ownership of
improvement efforts and that the efforts be tailored
to local needs and conditions.
An emphasis on understanding local conditions
lies at the heart of the work of RAD-AID, an in-
ternational, nonprofit organization founded in
2008 that aims to expand the availability of med-
ical imaging services in developing countries.51
RAD-AIDhasdeveloped theRadiology-Readiness
assessment survey, a tool for evaluating how
available resources can best be used to improve
imaging in the service of population health in any
given locality.52,53 It calls for the collection of
detailed data on many subjects, including basic
local infrastructure (eg, transportation, telecom-
munications), the energy supply for powering
imaging equipment; the prevalence of commu-
nicable and noncommunicable diseases, and
the availability of drugs, healthcare personnel,
diagnostic tests, and medical procedures. It ad-
dresses the fact that the value of imaging de-
pends entirely on the context in which it is used.
For instance, a mammography program will ob-
viously be of little benefit if there are no surgeons,
radiation oncologists, or oncologists available to
treat breast cancers, and a donation of equip-
ment will be of no help in a place without elec-
tricity or personnel able to use and maintain it
properly.52,53 The information collected helps
determine whether a given intervention is worth-
while or what ancillary components may be
needed to make it so. The tool highlights the
importance of interdisciplinary collaboration in
advancing imaging services.
RAD-AID, which is affiliated with the United Na-
tions and the WHO, aims to foster partnerships
between nonprofit organizations, the private sec-
tor, government agencies, technology companies,
and health care institutions.54 The annual RAD-
AID conference brings together representatives
from these various types of entities to share their
ideas and their experiences working to improve
imaging services in developing countries. As high-
lighted in awhite paper from the2010conference,
keys to the long-term success of such efforts in-
clude business financing and training for imaging
entrepreneurs, the development of information
technologies for knowledge transfer, and the de-
velopment of effectivemodels for providingclinical
training and low-cost imaging.55
The organization Imaging the World (ITW) has
developed one promising model that combines
teleradiology with imaging technology that re-
quires limiteduser training.Specifically, ITW trains
local health-care staff to perform so-called volume
scanning ultrasoundprotocols, which require only
theuseof external landmarksandnoknowledgeof
internal structures; the imagescan thenbesent via
cell phone to radiologists with the expertise to
interpret them.55-57 ITW has garnered the support
of major donors, such as the Bill and Melinda
Gates Foundation, and has established partner-
ships with companies from the medical imaging
device and informatics industries. Theirmodel has
been piloted in Uganda as a means of monitoring
maternal and fetal health and has obvious poten-
tial applications for cancer care.57
Clinical trainingof staff in low-resource regionscan
be bolstered by online courses or learning mod-
ules, some of which are available on the websites
of RAD-AID and other organizations. However, to
foster long-term, systemic improvements and the
development of local expertise, face-to-face in-
tensive training programs are particularly valu-
able. Not only do they allow the acquisition of
practical, hands-on experience under direct su-
pervision but also they can foster the development
of long-term mentoring and strong cross-cultural
collaborative relationships. In turn, such relation-
ships can help trainees develop the leadership
skills and connections to effect change in their
countries of origin, such as the initiation of teach-
ing, research, or cancer screening programs.
One highly successful example of this kind of
approach is a teach-the-teachers program run
by the Jefferson University Research and Educa-
tion Institute (JUREI).55,58 In the JUREI program,
physicians from the developing world undergo
training in ultrasound at centers of excellence in
the United States and, subsequently, often go on
to establish training facilities in their home coun-
tries. To date, local training programs in ultra-
sound have been established at more than 70
JUREI-affiliated centers in 55 countries.58 The
JUREI program illustrates how, with a relatively
small investment of time and resources, it is pos-
sible tomake a positive impact that will continue to
grow over time. Health care institutions across the
United States and Europe are involved in interna-
tional outreach programs that aim to produce a
similar long-term effect.
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The large international imaging societies, through
their existing programs and activities, are uniquely
placed to promote scientific exchange and offer
education to radiologists from low-resource re-
gions. The European School of Radiology, for
example, works with imaging leaders in such
countries to identify outstanding candidates
for oncologic imaging fellowships in the United
States. In addition, the ESR recently took several
measures to strengthen its efforts in LatinAmerica,
including theprovisionof 100 subsidizedplaces at
the European Congress of Radiology exclusively
for Latin American applicants, as well as the
opening of an office in Bogota with a full-time staff
member to represent the society on site at Latin
American radiology congresses. The interest in
and need for such initiatives are reflected by the
fact that a large proportion of members of the
ESR—some 19%—are from Latin America.59
Governments of developing nations may also
reach out directly to foreign centers of excel-
lence or nonprofit organizations to develop
training programs, or they may work with in-
dustry to design customized imaging facilities
that meet their individual needs. Although
there is no one-size-fits-all solution to fulfilling
the cancer imaging needs of developing coun-
tries, the greater the number of people and
disciplines involved in the effort, the faster
solutions can be found and implemented. Po-
tential volunteers include not only experienced,
fully employed physicians and staff but also
trainees and recent retirees, whomay havemore
flexibility. For example, the recently formed In-
ternational Cancer Experts Corp, a member of
the Union for International Cancer Control,
seeks to include trainees, early career leaders,
senior health care workers, and retirees in mul-
tidisciplinary panels of experts assigned to pro-
vide training and mentoring in protocol-based
cancer care. Working through a designated hub
(which may be an academic center, private
practice, or professional organization in the de-
veloped world), the volunteer experts may be
asked to both conduct short initial training visits
to health care centers in low-income regions and
provide ongoing support through teleconferenc-
ing and telecommunications.60
International efforts to provide oncologic imaging
training and expertise in underserved regions
must be accompanied by the political will from
the governments of these regions to develop long-
term strategies to improve diagnostic facilities and
expand the availability of imaging equipment and
treatment. Furthermore, to ensure the sustainabil-
ity of any improvements, measures must be taken
to retain trained and specialized oncologic radiol-
ogists and oncologists in the public service and
give them appropriate resources and structures to
train others.
In conclusion, cancer asamajor global healthcare
problem is expected to worsen because of a grow-
ing and aging population as well as harmful envi-
ronmental conditions in expanding urban areas,
especially in developing countries. The quality of
patient careeverywhere isaffectedby thequalityof
cancer imaging. Dramatic regional disparities in
the availability of imaging equipment need to be
addressed. Furthermore, there is a shortage of
appropriately trained oncologic imagers world-
wide. To advance oncologic imaging, training op-
portunities in both developed and developing
countries must be expanded and tailored to re-
gional needs. Large professional societies have
increasingly been providing leadership in the cre-
ationof clinicalpracticeguidelinesandcurriculum
development as well as offering online and in-
person learning opportunities. More such efforts
are needed, along with increased advocacy to
raise awareness of the importance and complexity
of oncologic imaging among the medical commu-
nity andgovernmentpolicymakers.With respect to
improving oncologic imaging in low-resource
countries in particular, businesses, nonprofit or-
ganizations, and health care institutions have
demonstrated that it is possible to establish suc-
cessful collaborations with local governments and
health care organizations either directly or by
working through member organizations such as
RAD-AID. Tools for telemedicine can be of great
help to these efforts, as will developments in
artificial intelligence. Nevertheless, the unmet
needs for oncologic imaging around the world
remain vast. Radiologists at all levels—those in
training, midcareer, or even retired—are greatly
needed to contribute clinical expertise, teaching
skills andmentorship inmultidisciplinary efforts to
improve cancer care.
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